Steris (STE) Income from Discontinued Operations (2022 - 2025)
Steris (STE) posted Income from Discontinued Operations of -$800000.0 for Q1 2025, down 700.0% on a QoQ basis from -$100000.0 in Q4 2024, and up 99.48% year-over-year from -$401039.6 in Q1 2024.
Analysis
Steris (STE) Income from Discontinued Operations (2022 - 2025) Analysis & Trends
Steris has reported Income from Discontinued Operations for 4 years, with the latest figure at -$800000.0 in Q1 2025.
- On a quarterly basis, Income from Discontinued Operations rose 99.48% year-over-year to -$800000.0 in Q1 2025; TTM through Dec 2025 was -$800000.0, a 99.46% increase from a year earlier, with the FY2025 full-year figure at $4.5 million, up 102.6% from the prior year.
- Income from Discontinued Operations was -$800000.0 for Q1 2025 at Steris, down from -$100000.0 in the prior quarter.
- The five-year high for Income from Discontinued Operations was $5.6 million in Q2 2024, with the low at -$439.1 million in Q3 2022.
- Average Income from Discontinued Operations over 4 years is -$51.6 million, with a median of -$5.6 million recorded in 2023.
- The largest YoY upside for Income from Discontinued Operations was 182.46% in 2024 against a maximum downside of 3338.22% in 2024.
- Over 4 years, Income from Discontinued Operations stood at -$7.7 million in 2022, then rose by 0.29% to -$7.7 million in 2023, then jumped by 98.69% to -$100000.0 in 2024, then tumbled by 700.0% to -$800000.0 in 2025.
- The last three Income from Discontinued Operations figures came in at -$800000.0 (Q1 2025), -$100000.0 (Q4 2024), and -$200000.0 (Q3 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn | - |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn | - |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn | - |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn | - |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn | - |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn | - |
| 10 | Zimmer Biomet Holdings | 18.00 Bn | 17.59 Bn | 1.54 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | -800,000.00 |
| Dec 31, 2024 | -100,000.00 |
| Sep 30, 2024 | -200,000.00 |
| Jun 30, 2024 | 5.60 Mn |
| Mar 31, 2024 | -154.30 Mn |
| Dec 31, 2023 | -7.66 Mn |
| Sep 30, 2023 | -4.45 Mn |
| Jun 30, 2023 | -6.79 Mn |
| Mar 31, 2023 | 4.77 Mn |
| Dec 31, 2022 | -7.68 Mn |
| Sep 30, 2022 | -439.14 Mn |
| Jun 30, 2022 | -8.33 Mn |